Breast Cancer News and Research

Latest Breast Cancer News and Research

Leading experts in health and health care reform to take part in symposium

With the nation facing a $9 trillion deficit over the next 10 years, according to government estimates, the future of health care reform depends upon a neglected but critical leg of the equation: cost. Some of the nation’s leading experts in health and health care reform will provide insights into this issue when they converge in Nashville Saturday for a nonpartisan public discussion.

29 Aug 2009

Cancer Immunotherapy Index of ten cancer immunotherapy stocks increases by 23%

The Cancer Immunotherapy Index of ten leading cancer immunotherapy stocks increased 23% since its inception July 10, 2009. The CI Index was developed by Mentor Capital as a peer group index against which investors could bench mark stock performance in the rapidly growing immunotherapy sector.

29 Aug 2009

Research round-up: Highlights from recent releases

American Health Care Association (AHCA): State-by-State Medicare Cuts to Nursing Homes -- "A new [AHCA] analysis of the pending House health reform bill [HR 3200], combined with the impact of a recently-enacted Medicare regulation cutting Medicare-funded nursing home care by $12 billion over ten years, finds seniors in fifteen states requiring nursing and rehabilitative care will face total funding cuts in excess of $1 billion over that same time period," according to an AHCA description of the study. "The assessment was based on the Congressional Budget Office (CBO) score of both HR 3200 and the recent CMS funding rule, along with Medicare Skilled Nursing Facility (SNF) utilization data." A breakdown of each of the 15 states facing ten-year billion dollar cuts to Medicare-funded nursing homes is available online (8/20).

28 Aug 2009

TRAF6 protein can activate a cell signalling molecule associated with cancer

The mainstay immune system protein TRAF6 plays an unexpected, key role activating a cell signaling molecule that in mutant form is associated with cancer growth, researchers at The University of Texas M. D. Anderson Cancer Center report in the Aug. 28 edition of Science.

28 Aug 2009

Springer signs agreement with The Endocrine Society to co-publish a new journal

Springer, one of the leading publishers in the fields of science, technology and medicine, has signed an agreement with The Endocrine Society to co-publish a new journal, Hormones & Cancer, starting in January 2010.

28 Aug 2009

Kingston General Hospital adopts Sentinelle Medical's new breast imaging system through HTAIP

Dr. Morris (Mickey) Milner, President and CEO of The Health Technology Exchange (HTX), announced the successful adoption of Sentinelle Medical's new breast imaging system by Kingston General Hospital (KGH), through the HTX's Health Technology Assessment and Implementation Program (HTAIP), a program funded by the Ontario Ministry of Research and Innovation.

28 Aug 2009

Chk1 and Fbx6 play an important role for the regulation of response to chemotherapy

Cell cycle checkpoints act like molecular tripwires for damaged cells, forcing them to pause and take stock. Leave the tripwire in place for too long, though, and cancer cells will press on regardless, making them resistant to the lethal effects of certain types of chemotherapy, according to researchers at the Salk Institute for Biological Studies.

28 Aug 2009

Resonant Medical's multi-anatomy Clarity System to be exhibited at ESTRO, Netherlands

Resonant Medical, an innovator in soft tissue planning, image-guidance and adaptive radiotherapy products, today announced that the Company will be exhibiting the next generation of its multi-anatomy Clarity System at the 10th Biennial Meeting of The European Society of Therapeutic Radiology and Oncologists (ESTRO), being held in Maastricht, Netherlands.

27 Aug 2009

Four medical groups of Resurrection Health Care Preferred earn nine blue stars in the 2009 Blue Star Report

Three out of four medical groups of Resurrection Health Care Preferred (RHCP) have earned nine blue stars, a perfect score, in the 2009 Blue Star Report -- an annual ranking of doctors in medical groups from Blue Cross Blue Shield of Illinois.

27 Aug 2009

Novelos Therapeutics enters into a definitive agreement with Purdue Pharma to raise funds

Novelos Therapeutics, Inc. (OTCBB: NVLT), a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that Novelos entered into a definitive agreement with Purdue Pharma L.P., an existing investor, to sell 13,636,364 shares of its common stock and warrants, expiring on December 31, 2015, to purchase an aggregate of approximately 4,772,728 shares of common stock at an exercise price of $0.66 per share, for gross proceeds of $9 million.

27 Aug 2009

Angiotensin arrests lung tumor growth by inhibiting blood vessel formation

In new animal research done by investigators at Wake Forest University School of Medicine, scientists have discovered a treatment effective in mice at blocking the growth and shrinking the size of lung cancer tumors, one of the leading causes of cancer death in the world.

27 Aug 2009

Fight against brain tumor will result in greater awareness and positive outcomes

With this morning's passing of Massachusetts Senator Ted Kennedy from a brain tumor, Wilmington's Christopher Grundner says he feels that it could lead to quicker diagnoses for others affected by the disease and more support for the cause.

27 Aug 2009

New website launched for comparing mortality risks by gender, age, cause of death and geographic region

A new Web site, www.DeathRiskRankings.com, developed by researchers and students at Carnegie Mellon University, allows users to query publicly available data from the United States and Europe, and compare mortality risks by gender, age, cause of death and geographic region. The Web site not only gives the risk of dying within the next year, but it also ranks the probable causes and allows for quick side-by-side comparison between groups.

26 Aug 2009

UT Southwestern awarded $763,000 as grant to expand studies of Peregrine's anti-PS antibodies

Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM) today announced that the U.S. National Institute of Allergy and Infectious Diseases (NIAID) has awarded a two-year, $763,000 grant to Philip Thorpe, Ph.D., of the University of Texas Southwestern Medical Center for research expanding its studies of anti-phosphatidylserine (anti-PS) antibodies as potential treatments for viral hemorrhagic fever (VHF) infections.

26 Aug 2009

Lifeline Biotechnologies to establish a demonstration site for its First Warning System

Lifeline Biotechnologies, Inc. today announced that it is preparing to establish a demonstration site for its First Warning System to be located in Reno, Nevada.

26 Aug 2009

Tamoxifen drug poses increased risk of developing ER negative breast cancer

While long-term tamoxifen use among breast cancer survivors decreases their risk of developing the most common, less aggressive type of second breast cancer, such use is associated with a more than four-fold increased risk of a more aggressive, difficult-to-treat type of cancer in the breast opposite, or contralateral, to the initial tumor.

26 Aug 2009

FDA clears Aperio Technologies to market breast tissue image analysis application

Aperio Technologies, Inc., (Aperio), a global leader in digital pathology for the healthcare and life sciences industry, has received clearance from the U.S. Food and Drug Administration (FDA) to market the IHC HER2 Breast Tissue Image Analysis application, available through its patented digital pathology platform.

25 Aug 2009

Elevated levels of GLI1 protein linked to unfavorable prognosis and progressive stages in human breast cancer

Elevated levels of GLI1 (glioma-associated oncogene homolog 1) protein in human breast cancer are associated with unfavorable prognosis and progressive stages of disease. Researchers writing in the open access journal BMC Cancer found increased expression of GLI1 in samples taken from more advanced and less survivable tumors.

25 Aug 2009

Phase I/II trial of Amphinex uses photochemical internalisation approach

PCI Biotech Holding ASA, the Norwegian drug delivery company focusing on effective delivery of cancer therapeutics, today announced that the first patient has received treatment in the Phase I/II trial with the lead candidate Amphinex(R), which uses a new approach called photochemical internalisation.

25 Aug 2009

DS Waters of America forges alliance with breast cancer advocacy group

DS Waters of America, Inc., a leader in the home and office bottled water, filtration and office coffee delivery service today announced it has entered a three-year alliance with Susan G. Komen for the Cure(R), the world's largest breast cancer advocacy group.

24 Aug 2009

Breast Cancer News and Research

Latest Breast Cancer News and Research

Leading experts in health and health care reform to take part in symposium

Cancer Immunotherapy Index of ten cancer immunotherapy stocks increases by 23%

Research round-up: Highlights from recent releases

TRAF6 protein can activate a cell signalling molecule associated with cancer

Springer signs agreement with The Endocrine Society to co-publish a new journal

Kingston General Hospital adopts Sentinelle Medical's new breast imaging system through HTAIP

Chk1 and Fbx6 play an important role for the regulation of response to chemotherapy

Resonant Medical's multi-anatomy Clarity System to be exhibited at ESTRO, Netherlands

Four medical groups of Resurrection Health Care Preferred earn nine blue stars in the 2009 Blue Star Report

Novelos Therapeutics enters into a definitive agreement with Purdue Pharma to raise funds

Angiotensin arrests lung tumor growth by inhibiting blood vessel formation

Fight against brain tumor will result in greater awareness and positive outcomes

New website launched for comparing mortality risks by gender, age, cause of death and geographic region

UT Southwestern awarded $763,000 as grant to expand studies of Peregrine's anti-PS antibodies

Lifeline Biotechnologies to establish a demonstration site for its First Warning System

Tamoxifen drug poses increased risk of developing ER negative breast cancer

FDA clears Aperio Technologies to market breast tissue image analysis application

Elevated levels of GLI1 protein linked to unfavorable prognosis and progressive stages in human breast cancer

Phase I/II trial of Amphinex uses photochemical internalisation approach

DS Waters of America forges alliance with breast cancer advocacy group

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Breast Cancer News and Research

Latest Breast Cancer News and Research

Industry Focus eBook - Oncology (1st Edition) eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in